Could a cold virus drug shield COPD lungs?
Disease control
Completed
This study tested an experimental drug called vapendavir in 52 adults with COPD (a chronic lung disease). The goal was to see if the drug could reduce severe cold symptoms caused by rhinovirus, a common cold virus. Participants were given either vapendavir or a placebo and monito…
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 07:03 UTC